Abstract
Purpose
To evaluate the ability of ophthalmologists to predict the laboratory results of presumed microbial keratitis and to explore which findings might influence diagnostic prognostication.
Design
Prospective cross-sectional study.
Methods
Fifteen ophthalmologists completed study forms at the initial presentation of patients with presumed microbial keratitis. After predicting the category of microbial recovery, clinicians submitted corneal scrapings for masked laboratory processing. The relative effects of ocular inflammatory signs on correct microbial diagnosis were explored with Poisson regression.
Results
Clinical examiners correctly predicted the presence or absence of microbial recovery in 79 (76%) of 104 ulcerative keratitis and successfully distinguished among bacterial, fungal, and amoebic keratitis for 54 (73%) of 74 culture-positive infections, although only 31 (42%) were properly subcategorized. The positive predictive value of clinical diagnosis was 65% (95% confidence interval (CI), 43%–84%) for 20 eyes with Pseudomonas keratitis, 48% (95% CI, 32%–63%) for 38 other bacterial keratitis, 45% (95% CI, 17%–77%) for 13 fungal keratitis, and 89% (95% CI, 52%–100%) for nine Acanthamoeba keratitis. The recognition of Pseudomonas keratitis was significantly improved by the occurrence of a larger infiltrate (P = .02), and correctly predicting Acanthamoeba keratitis was enhanced by observing a ring infiltrate (P < .001). Antimicrobial use before referral significantly attenuated clinical diagnosis (P = 0.03) and hampered microbial recovery (P = 0.004).
Conclusions
Established Pseudomonas keratitis and Acanthamoeba keratitis can be suspected before laboratory confirmation, but overlapping inflammatory features and recent empiric antimicrobial treatment limits etiologic recognition of most microbial corneal infections.
The clinical diagnosis of microbial keratitis often relies on a history of infectious exposure and the morphological features of corneal inflammation.1 Ophthalmologists use clinical clues to recognize ocular surface infection,2 and some distinctive though not pathognomonic signs may help to differentiate bacterial, fungal, and amoebic pathogens of the cornea.3–5
Laboratory demonstration of the infective agent in a corneal sample is recommended6 but may not be regularly obtained due to time, cost, and availability.7, 8 Initial antimicrobial therapy is often guided by subjective interpretation of presenting clinical features.9 We aimed to determine the predictive value of ophthalmologists’ opinions about presumed microbial keratitis before microbiological tests were known. We also sought to identify which findings of the history or examination might affect provisional judgments about responsible microorganisms.
METHODS
After obtaining institutional review board approval, selected faculty, cornea fellows, and senior ophthalmology residents gave written consent to complete a survey instrument immediately before performing a diagnostic corneal scraping when encountering a patient with presumed microbial keratitis for whom laboratory evaluation was planned. The proforma required an opinion about the most likely infective etiology, selected from a list of microorganisms that consisted of staphylococci, Streptococcus pneumoniae, viridans streptococci, Pseudomonas aeruginosa, other gram-negative rods, nontuberculous Mycobacterium, Nocardia, Candida, Fusarium, other filamentous fungi, and Acanthamoeba. Predisposing risk factors, recent antiinfective and corticosteroid use within the preceding four days, and duration of symptoms were recorded. Examination findings were summarized by the size, type, location, and depth of ocular inflammation and corneal ulceration. The reticule of the slit-lamp biomicroscope was used to measure the longest diameter of the inflammatory infiltrate and its perpendicular, and the elliptical area was calculated from these dimensions. Completed surveys were prospectively collated.
Corneal scrapings were obtained under topical anesthesia with a sterile spatula for direct preparation of laboratory materials.10 Slides for gram and acridine orange stains were prepared. Specimens were directly inoculated to sheep blood and chocolate agar plates, inhibitory mould agar with gentamicin slant, and thioglycollate broth (BBL, Becton Dickinson, Sparks, MD). A buffered charcoal-yeast extract agar plate and Löwenstein-Jensen medium slant were used at the ophthalmologist’s discretion. Smeared slides and inoculated media were processed by the hospital microbiology laboratory that was not informed about the clinicians’ differential assessment. Isolates were identified by conventional biochemical methods or commercial identification kits. Fungi were corroborated at a reference mycology laboratory. Microbial keratitis was judged to be confirmed if the same microorganism was recovered from two separate culture media or if microbial growth was congruent with the paired smear.
The predicted etiology was compared with the principal laboratory isolate as the reference standard. Sensitivity, specificity, and predictive values were estimated with exact binomial confidence intervals (CIs) for any confirmed microbial recovery and for bacterial, fungal, and protozoal strata. Categorical signs were compared using Fisher’s exact test, and continuous variables were compared using a t-test or an equality-of-medians test. The effect of categorized risk factors and clinical signs on making a correct clinical diagnosis was explored with robust Poisson regression using Intercooled Stata version 9.11 Statistical significance was set at P < .05.
RESULTS
Survey forms were completed for 104 unilateral cases of ulcerative keratitis from July 2004 through April 2006 at three eye clinics in one medical center. Fifty-two (50%) corneal scrapings yielded bacteria, 13 (12.5%) grew fungi, 9 (9%) yielded Acanthamoeba, and 30 (29%) had no growth (Table 1). Sixty-eight (92%) of 74 culture-positive cases were correctly predicted to have any microbial recovery, and 15 (75%) of P. aeruginosa infections and 8 (89%) of Acanthamoeba infections had these isolates correctly predicted.
TABLE 1.
Microbial Recovery from Corneal Scrapings and Clinical Prediction of Corneal Isolates
The sensitivity of smear evaluation was 34% (95% CI, 23%–46%) among 71 culture-positive eyes that had corneal scrapings processed for light microscopy, and the positive predictive value of stained smears was 100% (95% CI, 74%–100%). The median duration of symptoms was four days (25% and 75% quartiles, 3 and 10 days). Contact lenses were worn in 23 bacterial keratitis, 6 fungal infections that were each associated with ReNu products (Bausch & Lomb, Rochester, NY), and 9 Acanthamoeba infections. Among 61 patients using an antimicrobial medication at presentation, 46 (75%) used a fluoroquinolone, 13 another antibacterial, one an antifungal, and one an antiamebic agent. Recent antimicrobial therapy occurred in 37 (50%) of 74 culture-positive eyes and 24 (80%) of 30 culture-negative eyes (P = .004).
Eighty-nine (86%) survey forms were completed by corneal specialists, and 15 (14%) by senior ophthalmology residents. Faculty did not differ from residents in correctly predicting culture positivity (P = 0.81). Clinicians correctly classified culture-positive and culture-negative keratitis in 79 (76%; 95% CI, 67%–84%) eyes. The sensitivity, specificity, positive predictive value, and negative predictive value for the clinical diagnosis of any culture-confirmed corneal infection were 92% (95% CI, 83%–97%), 37% (95% CI, 20%–56%), 78% (95% CI, 68%–86%), and 65% (95% CI, 38%–86%), respectively.
Clinicians correctly distinguished the microbial kingdom for 54 (73%) of 74 culture-positive infections, including 41 (79%) of 52 bacterial keratitis, 5 (38%) of 13 fungal keratitis, and 8 (89%) of 9 amoebic keratitis and correctly categorized 11 (37%) of 30 sterile infiltrates that had corneal scrapings (Figure). Duration of symptoms of 4 days or less, the lack of recent antimicrobial treatment, and the presence of a ring infiltrate significantly improved clinical prediction of bacterial, fungal, amoebic, or sterile keratitis (Table 2).
FIGURE.
Ophthalmologists’ ability to predict the presence and type of microbial recovery from presumed microbial keratitis.
TABLE 2.
Relative Effect of Risk Factors and Clinical Signs on Correctly Predicting Bacterial, Fungal, Amoebic, or Sterile Keratitis
Characteristic | No. (%) (n = 104) | Risk Ratio (95% Confidence Interval) | P Value |
---|---|---|---|
Symptomatic duration ≤ 4 days | 53 (51%) | 1.64 (1.19–2.28) | .003 |
Contact lens wear | 55 (53%) | 1.18 (0.87–1.60) | .30 |
Prior corneal disorder or injury | 38 (51%) | 0.87 (0.64–1.18) | .37 |
No recent antimicrobial use | 43 (41%) | 1.38 (1.03–1.84) | .032 |
Recent corticosteroid use | 36 (35%) | 0.84 (0.60–1.18) | .31 |
Epithelial defect | 91 (87%) | 1.02 (0.64–1.61) | .94 |
Central corneal infiltrate | 60 (58%) | 0.97 (0.72–1.31) | .84 |
Area of corneal infiltrate > 4 mm2 | 50 (48%) | 1.11 (0.83–1.50) | .48 |
Stromal infiltrate of deeper third | 23 (22%) | 0.88 (0.59–1.31) | .53 |
Stromal ulceration > one third depth | 22 (21%) | 0.76 (0.49–1.19) | .23 |
Multifocal stromal infiltrates | 23 (22%) | 0.80 (0.52–1.22) | .29 |
Ring stromal infiltrate | 7 (7%) | 1.41 (1.00–1.99) | .050 |
Inflammatory endothelial plaque | 13 (12%) | 0.71 (0.39–1.31) | .27 |
Hypopyon | 26 (25%) | 1.06 (0.76–1.48) | .72 |
Correct clinical prediction of microbial etiology varied among microbial categories. The probability of a particular category of infection following a positive clinical diagnosis was greater for Pseudomonas keratitis and for Acanthamoeba keratitis than for other bacterial or fungal infections (Table 3). The correct clinical diagnosis of Pseudomonas keratitis occurred 2.96 (95% CI, 1.14–7.68) times more often when the infiltrate area exceeded 8 mm2 (P = .026). The correct prediction of Acanthamoeba keratitis occurred 23.1 (95% CI, 6.86–77.8) times more often when a ring infiltrate was present (P < .001).
TABLE 3.
Diagnostic Performance of Clinical Prediction for Categories of Microbial Keratitis
Diagnosis | Sensitivity (95% CI) | Specificity (95% CI | Positive predictive value (95% CI | Negative predictive value (95% CI |
---|---|---|---|---|
Pseudomonal keratitis | 75% (51%–91%) | 90% (82%–96%) | 65% (43%–84%) | 94% (86%–98%) |
Other bacterial keratitis | 66% (47%–81%) | 68% (56%–79%) | 48% (32%–63%) | 82% (70%–90%) |
Fungal keratitis | 38% (14%–68%) | 93% (86%–97%) | 45% (17%–77%) | 91% (84%–96%) |
Acanthamoeba keratitis | 89% (52%–100%) | 99% (94%–100%) | 89% (52%–100%) | 99% (94%–100%) |
CI, confidence interval.
Thirty-one (42%) of 74 culture-positive infections had the bacterial genus, fungal category, or Acanthamoeba correctly predicted. Misdiagnoses included one candidal keratitis that was clinically suspected to be staphylococcal, one Staphylococcus aureus keratitis clinically diagnosed as candidal, two filamentous fungal infections thought to be pseudomonal, four Serratia marcescens keratitis diagnosed as staphylococcal, one Nocardia keratitis predicted to be fungal, one Eikenella keratitis diagnosed as Pseudomonas keratitis, and 3 cases of coagulase-negative staphylococcal keratitis suspected to be sterile.
DISCUSSION
We studied the predictive value of clinical decision-making in the evaluation of ulcerative keratitis. At presentation, clinicians could often distinguish infected eyes from sterile infiltrates, but the use of topical antibiotics before corneal specimen collection made this judgment more difficult. Because the majority of patients with ulcerative keratitis referred for diagnosis and management were already using antibiotics, provisional determination and rapid laboratory confirmation of the etiology of microbial keratitis were problematic.12
Ophthalmologists were reasonably good at identifying Pseudomonas keratitis, apparently by recognizing the association of a large suppurative infiltrate with gram-negative bacterial infection.13 Several amoebic infections presented with a stromal ring infiltrate resulting in a high sensitivity and specificity for diagnosing advanced Acanthamoeba keratitis.5 In contrast, the predictive values for clinically classifying other bacterial or fungal keratitis were modest. The proportion of correctly predicted fungal infections was less than expected,1 and we doubt that clinical features could dependably replace laboratory investigation of keratomycosis.13 While the occurrence and type of corneal infection could often be discerned, less than half had bacterial genus, fungal category, or Acanthamoeba correctly predicted.
Several limitations could affect the validity of our findings. Our study took place at a subtropical referral center that treated a range of corneal infections including unusual bacterial isolates such as Pseudomonas oryzihabitans and Kingella denitrificans and uncommon fungal pathogens such as Verticillium.14 Enrollment also occurred during an apparent national resurgence of Acanthamoeba keratitis15 and in the course of an international epidemic of Fusarium keratitis associated with contact lens wear.16 As we included both primary care and referral clinics, the results may have been affected if atypical or nonresponsive infections were more difficult to recognize and to classify. The findings could have been biased in the opposite direction if progressive infections were not referred until distinctive features materialized. For example, the majority of cases of Acanthamoeba keratitis had a ring infiltrate, but this finding is often not seen in the early stage of infection when laboratory investigations may be a better indication for starting treatment. Since this study blends several levels of referral patterns the results should be generalized with caution. Expanding this study to other locations could perhaps reveal other attributes that affect ophthalmologists’ clinical decision-making.
Despite these shortcomings, we believe that our experience shows the complementary roles of clinical and laboratory evaluation. The good specificity for recognizing several corneal infections should encourage ophthalmologists to communicate their preliminary diagnostic suspicions to microbiologists. However, clinical examination cannot be the only basis for deciding how to treat suspected microbial keratitis. Beginning empiric antimicrobial therapy without laboratory evaluation may delay correct diagnosis and proper care if improvement does not promptly take place. The microbiological identification of specific microbial isolates is a more reliable guide for the individualized treatment of microbial keratitis.
Acknowledgments
This study was supported by research (EY013782) and core (EY02520) grants from the National Eye Institute, National Institutes of Health, Bethesda, Maryland; a senior scientific investigator award from the Research to Prevent Blindness, Inc., New York, New York; and a research grant from the Sid W. Richardson Foundation, Fort Worth, Texas. The authors indicate no financial conflict of interest. Involved in study design (K.R.W.); involved in conduct of study (M.A.D.); involved in data collection (M.A.D., A.L.); involved in management, analysis, and interpretation of the data (M.A.D., K.R.W.); and involved in preparation, review, and approval of the manuscript (M.A.D., A.L., K.R.W.). Drs. D.B. Jones, A.Y. Matoba, M.B. Hamill, S.C. Pflugfelder, and M.P. Weikert contributed to this study. Corneal scrapings were processed by clinical microbiologists at The Methodist Hospital, Ben Taub General Hospital, and Michael E. DeBakey Veterans Affairs Medical Center, Houston.
Biography
Matthew A. Dahlgren, MD is in private practice at Milwaukee Eye Care Associates in Milwaukee, Wisconsin. He received his medical degree from the Medical College of Wisconsin in 2001, and was elected to Alpha Omega Alpha. His residency training in ophthalmology was at the Cullen Eye Institute at Baylor College of Medicine, where he also served as chief resident. Afterwards, he completed a fellowship in cornea and anterior segment surgery at the University of Minnesota.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Saini JS, Jain AK, Kumar S, Vikal S, Pankaj S, Singh S. Neural network approach to classify infective keratitis. Curr Eye Res. 2003;27:111–116. doi: 10.1076/ceyr.27.2.111.15949. [DOI] [PubMed] [Google Scholar]
- 2.Rietveld RP, ter Riet G, Bindels PJ, Sloos JH, van Weert HC. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ. 2004;329:206–210. doi: 10.1136/bmj.38128.631319.AE. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wilhelmus KR. Bacterial keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection & immunity. St. Louis: Mosby; 1996. pp. 970–1031. [Google Scholar]
- 4.Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol. 2005;89:1554–1558. doi: 10.1136/bjo.2005.076315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Theodore FH, Jakobiec FA, Juechter KB, et al. The diagnostic value of a ring infiltrate in acanthamoebic keratitis. Ophthalmology. 1985;92:1471–1479. doi: 10.1016/s0161-6420(85)33830-7. [DOI] [PubMed] [Google Scholar]
- 6.Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology. 1981;88:814–820. doi: 10.1016/s0161-6420(81)34943-4. [DOI] [PubMed] [Google Scholar]
- 7.Pepose JS, Wilhelmus KR. Divergent approaches to the management of corneal ulcers. Am J Ophthalmol. 1992;114:630–632. doi: 10.1016/s0002-9394(14)74496-4. [DOI] [PubMed] [Google Scholar]
- 8.McDonnell PJ. Empirical or culture-guided therapy for microbial keratitis? A plea for data. Arch Ophthalmol. 1996;114:84–87. doi: 10.1001/archopht.1996.01100130080013. [DOI] [PubMed] [Google Scholar]
- 9.Daniell M, Mills R, Morlet N. Microbial keratitis: what’s the preferred initial therapy? Br J Ophthalmol. 2003;87:1167. doi: 10.1136/bjo.87.9.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wilhelmus KR, Liesegang TJ, Osato MS, Jones DB. Cumitech. 13A. Washington DC: American Society for Microbiology; 1994. Laboratory diagnosis of ocular infections. [Google Scholar]
- 11.Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706. doi: 10.1093/aje/kwh090. [DOI] [PubMed] [Google Scholar]
- 12.Marangon FB, Miller D, Alfonso EC. Impact of prior therapy on the recovery and frequency of corneal pathogens. Cornea. 2004;23:158–164. doi: 10.1097/00003226-200403000-00009. [DOI] [PubMed] [Google Scholar]
- 13.Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834–838. doi: 10.1136/bjo.87.7.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Shin JY, Kim HM, Hong JW. Keratitis caused by Verticillium species. Cornea. 2002;21:240–242. doi: 10.1097/00003226-200203000-00027. [DOI] [PubMed] [Google Scholar]
- 15.Joslin CE, Tu EY, McMahon TT, Passaro DJ, Stayner LT, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol. 2006;142:212–217. doi: 10.1016/j.ajo.2006.04.034. [DOI] [PubMed] [Google Scholar]
- 16.Chang DC, Grant GB, O’Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953–963. doi: 10.1001/jama.296.8.953. [DOI] [PubMed] [Google Scholar]